Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA.

Genet Med. 2011 Nov;13(11):913-20. doi: 10.1097/GIM.0b013e3182368a0e.

PMID:
22005709
2.

Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.

Lau TK, Jiang F, Chan MK, Zhang H, Lo PS, Wang W.

J Matern Fetal Neonatal Med. 2013 Mar;26(4):434-7. doi: 10.3109/14767058.2012.733768. Epub 2012 Oct 29.

PMID:
23035860
3.

Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.

Mooney RA, Peterson CJ, French CA, Saller DN Jr, Arvan DA.

Obstet Gynecol. 1994 Aug;84(2):298-303.

PMID:
7518896
4.

Noninvasive prenatal diagnosis empowered by high-throughput sequencing.

Chiu RW, Lo YM.

Prenat Diagn. 2012 Apr;32(4):401-6. doi: 10.1002/pd.3822. Review.

PMID:
22467171
5.

Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.

Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH.

Am J Obstet Gynecol. 2012 Apr;206(4):322.e1-5. doi: 10.1016/j.ajog.2012.01.029. Epub 2012 Jan 24.

PMID:
22464073
6.

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM.

BMJ. 2011 Jan 11;342:c7401. doi: 10.1136/bmj.c7401.

7.
9.

DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.

Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE.

Prenat Diagn. 2012 Aug;32(8):730-4. doi: 10.1002/pd.3892. Epub 2012 May 14.

PMID:
22585317
10.

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA.

Genet Med. 2012 Mar;14(3):296-305. doi: 10.1038/gim.2011.73. Epub 2012 Feb 2.

11.

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group.

Obstet Gynecol. 2012 May;119(5):890-901. doi: 10.1097/AOG.0b013e31824fb482. Erratum in: Obstet Gynecol. 2012 Oct;120(4):957.

PMID:
22362253
12.

Down's syndrome: current screening techniques.

White RS 3rd.

South Med J. 1989 Dec;82(12):1483-6.

PMID:
2480649
13.

[Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].

Qi QW, Jiang YL, Liu JT, Bian XM, Li Y, Lü SM, Zhu BS, Wang H, Xu ZF, Pan XY, Cai Y.

Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):737-41. Chinese.

PMID:
19087538
14.

Advances in antenatal screening for Down syndrome.

Wald NJ, Hackshaw AK.

Baillieres Best Pract Res Clin Obstet Gynaecol. 2000 Aug;14(4):563-80. Review.

PMID:
10985931
15.

Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.

Cole LA, Acuna E, Isozaki T, Palomaki GE, Bahado-Singh RO, Mahoney MO.

Prenat Diagn. 1997 Dec;17(12):1125-33.

PMID:
9467809
16.

Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy.

Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM, Palomaki GE, Bianchi DW.

Clin Chem. 2003 Feb;49(2):239-42.

17.

Free beta-hCG subunit versus intact hCG in Down syndrome screening.

Wenstrom KD, Owen J, Chu DC, Boots L.

Obstet Gynecol. 1997 Sep;90(3):370-4.

PMID:
9277646
19.

Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.

Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA.

N Engl J Med. 1994 Apr 21;330(16):1114-8.

20.

The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.

Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE.

Prenat Diagn. 2013 Jul;33(7):667-74. doi: 10.1002/pd.4126. Epub 2013 May 31.

PMID:
23592541

Supplemental Content

Support Center